Mysore Petro Chemicals (BSE 506734)₹131.45−1.83%Trading - Chemicals
In the Sep 2026 quarter (consolidated), Mysore Petro Chemicals reported sales of ₹9.42 Cr, up 86.9% from Sep 2025, and net profit of ₹8.98 Cr, up 9,877.8% year on year. For the year to Mar 2026, sales were ₹52.11 Cr and net profit ₹0.99 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.80 | 15.22 | 13.91 | 9.17 | 6.41 | 7.46 | 7.27 | 5.04 | 18.36 | 21.64 | 11.46 | 9.42 |
| Expenses | 8.70 | 18.93 | 18.46 | 10.65 | 7.60 | 8.05 | 9.67 | 6.88 | 22.59 | 23.99 | 11.78 | 10.15 |
| Operating Profit | −2.91 | −3.76 | −4.57 | −1.49 | −1.21 | −0.61 | −2.41 | −1.85 | −4.25 | −2.37 | −0.34 | −0.75 |
| OPM % | −50.0% | −24.6% | −32.7% | −16.1% | −18.7% | −8.0% | −33.0% | −36.5% | −23.1% | −10.9% | −2.9% | −7.8% |
| Other Income | 3.04 | 4.49 | 19.65 | 0.39 | −7.83 | 4.02 | 2.37 | 1.76 | 1.94 | 6.00 | 13.20 | 12.48 |
| Interest | 0.04 | 0.21 | 0.41 | 0.03 | 0.03 | 0.03 | 0.01 | 0.03 | 0.01 | 0.03 | 0.03 | 0.03 |
| Depreciation | 0.10 | 0.45 | 0.99 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Profit before tax | 0.00 | 0.07 | 13.62 | −1.20 | −9.10 | 3.29 | −0.14 | −0.19 | −2.41 | 3.51 | 12.71 | 11.58 |
| Tax % | 200.1% | 925.0% | 35.8% | 107.5% | −31.8% | 31.6% | 166.7% | −150.0% | −21.0% | 14.2% | 25.0% | 22.4% |
| Exceptional items | 0.00 | 0.00 | 7.99 | −6.99 | −12.98 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.02 | −0.66 | 8.72 | −2.50 | −6.19 | 2.25 | −0.39 | 0.09 | −1.90 | 3.01 | 9.54 | 8.98 |
| EPS (Rs) | −0.04 | −0.07 | 14.40 | −3.80 | −9.40 | 3.42 | −0.60 | 0.14 | −2.89 | 4.58 | 14.48 | 13.65 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.05 | 6.01 | 33.03 | 13.02 | 23.02 | 21.03 | 18.04 | 26.06 | 33.07 | 52.11 | 60.88 |
| Expenses | 25.02 | 10.01 | 36.01 | 16.01 | 25.04 | 24.02 | 26.02 | 30.02 | 39.06 | 60.10 | 68.51 |
| Operating Profit | 6.02 | −4.02 | −3.01 | −3.01 | −2.01 | −3.01 | −7.02 | −4.02 | −6.02 | −7.02 | −7.71 |
| OPM % | 19.1% | −57.0% | −9.9% | −19.9% | −9.0% | −12.9% | −38.9% | −17.0% | −17.0% | −14.0% | −12.7% |
| Other Income | 14.04 | 93.30 | 23.06 | 9.02 | 27.07 | 46.12 | 35.10 | 15.05 | 13.03 | 9.02 | 33.62 |
| Interest | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.10 |
| Depreciation | 2.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.32 |
| Profit before tax | 15.98 | 88.89 | 17.98 | 4.99 | 23.98 | 42.99 | 26.96 | 9.99 | 6.99 | 0.99 | 25.39 |
| Tax % | 6.0% | 19.1% | 4.0% | 10.1% | 109.1% | 23.1% | 23.1% | 25.0% | 59.1% | −5.0% | — |
| Exceptional items | 0.00 | 50.91 | 0.99 | 0.00 | 0.99 | 0.99 | 1.99 | 0.99 | 0.99 | 0.00 | 0.00 |
| Net Profit | 14.96 | 71.83 | 17.95 | 4.98 | −1.99 | 32.90 | 20.92 | 6.98 | 2.99 | 0.99 | 19.63 |
| EPS (Rs) | 22.26 | 108.63 | 26.93 | 7.36 | −3.39 | 49.50 | 31.38 | 11.32 | 4.61 | 1.22 | 29.82 |
| Dividend payout % | 4.0% | 2.0% | 7.0% | 27.0% | −59.0% | 5.0% | 8.0% | 22.0% | 43.0% | 163.1% | — |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.00 | 6.99 | 7.00 | 7.00 | 6.99 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 |
| Reserves | 70.15 | 141 | 157 | 160 | 157 | 188 | 207 | 215 | 216 | 218 |
| Borrowings | 5.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.01 | 0.00 | 0.00 |
| Other Liabilities | 9.95 | 4.98 | 5.97 | 5.97 | 30.86 | 39.80 | 44.78 | 63.69 | 51.75 | 70.66 |
| Total Liabilities | 93.09 | 152 | 169 | 173 | 194 | 234 | 258 | 304 | 275 | 296 |
| Fixed Assets | 32.06 | 19.04 | 16.04 | 16.04 | 15.03 | 16.03 | 15.02 | 48.06 | 14.03 | 14.02 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 0.00 | 0.00 |
| Investments | 54.04 | 79.05 | 107 | 115 | 145 | 213 | 228 | 232 | 243 | 254 |
| Other Assets | 5.99 | 54.02 | 45.98 | 41.98 | 34.01 | 5.01 | 15.01 | 22.99 | 16.99 | 28.01 |
| Inventories | 2.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.84 | 0.00 | 0.00 |
| Trade receivables | 1.65 | 0.00 | 0.40 | 0.74 | 4.88 | 1.69 | 5.27 | 9.78 | 7.96 | 23.86 |
| Cash & equivalents | 0.78 | 0.75 | 3.70 | 2.27 | 1.78 | 0.90 | 7.29 | 6.29 | 6.34 | 2.62 |
| Total Assets | 93.09 | 152 | 169 | 173 | 194 | 234 | 258 | 304 | 275 | 296 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 5.01 | −24.04 | −2.01 | −2.01 | −5.01 | −2.01 | −10.01 | −17.01 | −4.01 | 8.01 |
| Cash from investing activity | −3.01 | 25.01 | 6.01 | 1.99 | 5.99 | 1.99 | 18.02 | 23.03 | 6.01 | −11.01 |
| Cash from financing activity | −2.99 | −0.99 | −1.99 | −2.01 | −0.99 | −1.01 | −1.99 | −7.99 | −1.99 | −1.01 |
| Net cash flow | 0.00 | 0.00 | 2.99 | −0.99 | −0.99 | −0.99 | 5.98 | −0.99 | 0.00 | −3.99 |
| Capex | 2.46 | 0.36 | 0.00 | 0.00 | 0.00 | 1.28 | 0.29 | 1.90 | 0.00 | 0.20 |
| Free cash flow | 3.01 | −25.05 | 1.01 | −2.01 | −5.01 | −3.01 | −11.02 | −4.01 | −4.01 | 9.02 |
| CFO / OP % | 114.0% | 182.9% | 26.9% | 72.9% | 218.9% | 55.9% | 152.9% | 346.9% | 48.9% | −126.1% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 19 | 0 | 3 | 20 | 77 | 28 | 103 | 137 | 85 | 165 |
| Inventory days | 148 | 0 | 0 | 0 | 0 | 0 | 0 | 28 | 0 | 0 |
| Days payable | 151 | — | — | — | — | — | — | 27 | — | — |
| Cash conversion cycle | 17 | 0 | 4 | 21 | 78 | 29 | 104 | 139 | 86 | 166 |
| Working capital days | −46 | 642 | 139 | 411 | 290 | −6 | 82 | −85 | 29 | −16 |
| ROCE % | — | 21.1% | 11.0% | 3.0% | 19.0% | 24.1% | 12.1% | 5.0% | 8.0% | 0.0% |
For the Sep 2026 quarter, Mysore Petro Chemicals reported sales of ₹9.42 Cr, up 86.9% year on year and net profit of ₹8.98 Cr, up 9,877.8% year on year. The operating margin was −7.8%.
Mysore Petro Chemicals' sales for the year to Mar 2026 were ₹52.11 Cr; over the last twelve months they were ₹60.88 Cr.
Net profit for the year to Mar 2026 was ₹0.99 Cr, and ₹19.63 Cr over the last twelve months. Earnings per share over the same trailing period were ₹29.82.
Mysore Petro Chemicals reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹2.62 Cr.
Cash from operations was ₹8.01 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹9.02 Cr.